Number of the records: 1  

Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial

  1. 1.
    ROB, L., MALLMANN, P., KNAPP, P., MELICHAR, B., KLAT, J., MINÁŘ, L., NOVOTNÝ, Z., BARTŮŇKOVÁ, J., SPÍŠEK, R., PECEN, Ladislav, BIN HASSAN, H. I., CIBULA, D. Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial. Journal of Clinical Oncology. 2018, 36(15 S), 5509. ISSN 0732-183X. E-ISSN 1527-7755. Available: doi: 10.1200/JCO.2018.36.15_suppl.5509
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.